Company lists · Data refreshed September 2026
Top 25 Neuroscience drug developers based in the United Kingdom
RevenueBase identified 79 neuroscience drug developers headquartered in the United Kingdom as of September 2026 and tracks 4,513 professional contacts across them, including 1,240 with verified work emails. London is the largest hub.
This list covers neuroscience drug developers headquartered in the United Kingdom, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 20, 2026.
Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.
The 25 largest neuroscience drug developers based in the United Kingdom
Ranked by team size| # | Company | Contacts | |||
|---|---|---|---|---|---|
| 1 | 582 contacts → | ||||
Partial evidence “At Sygnature Discovery, a global drug discovery CRO, we create exceptional scientific outcomes.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 2 | 330 contacts → | ||||
Partial evidence “We develop and apply fragment and structure-based methods to solve problems in drug discovery, and have generated cell active lead compounds and development candidates against…” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 3 | 319 contacts → | ||||
Indirect evidence “Every day across Europe, Otsuka-people channel their passion and commitment into aiming to improve the health of our patients.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 4 | 229 contacts → | ||||
Indirect evidence “We are Compass, a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 5 | 214 contacts → | ||||
Partial evidence “hVIVO plc (Ticker: HVO) is a science‑led early‑phase drug development company purpose‑built to meet the growing complexity of modern clinical research.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 6 | 128 contacts → | ||||
Indirect evidence “We are recognised for our award-winning private mental health services, covering neurology, psychology and psychiatry.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 7 | 119 contacts → | ||||
Indirect evidence “Transpharmation is a contract research organisation led by scientists.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 8 | 119 contacts → | ||||
Indirect evidence “Britannia Pharmaceuticals, part of the STADA Arzneimittel AG group of companies, is a UK based pharmaceutical company specialising in the neurology market.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 9 | 92 contacts → | ||||
Indirect evidence “IXICO is no ordinary Imaging Contract Research Organisation (iCRO).” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 10 | 57 contacts → | ||||
Indirect evidence “Clerkenwell Health is building the UK’s leading specialist neuro and psychiatry site network, created to raise the standard of how CNS clinical trials are run.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 11 | 46 contacts → | ||||
Partial evidence “BDD combines drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and create new value-added products.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 12 | 29 contacts → | ||||
Indirect evidence “Pangea Bio is developing novel therapies that directly activate the TrkB receptor, driving neuronal and synaptic plasticity, and neuroprotection.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 13 | 28 contacts → | ||||
Indirect evidence “Unlocking New Targets to Transform the Treatment of Neurodegenerative Diseases” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 14 | 25 contacts → | ||||
Indirect evidence “Neuro-Bio has discovered a novel 14 amino acid bioactive peptide (T14) derived from the C terminus of AChE.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 15 | 23 contacts → | ||||
Indirect evidence “Built for precision, designed for patients.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 16 | 22 contacts → | ||||
Partial evidence “CoSyne Therapeutics is a vertically integrated AI Drug Discovery company aiming to bring speed to precision medicine through polymathic AI to help patients with under-served…” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 17 | 22 contacts → | ||||
Partial evidence “Drug discovery and development requires in-depth multi-disciplinary expertise which organisations may not always have in-house.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 18 | 18 contacts → | ||||
Indirect evidence “At AstronauTx our thesis is that changes in sleep architecture underpin disease and that sleep is a modifiable risk factor for chronic neurodegeneration.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 19 | 17 contacts → | ||||
Indirect evidence “PharmEnable is a biopharmaceutical company utilizing AI to discover effective small-molecule medicines for disease targets that are inaccessible to antibodies.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 20 | 14 contacts → | ||||
Indirect evidence Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 21 | 9 contacts → | ||||
Indirect evidence “NWPharmaTech is a Clinical Stage Biotech Company with a focus on Psychiatric & Neurological Disorders.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 22 | 8 contacts → | ||||
Indirect evidence “MeOmics capitalizes on recent advances in genetics and stem cell technology, combining genomics, phenomics and cellomics to create a unique Precision Psychiatry platform.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 23 | 8 contacts → | ||||
Indirect evidence “Leadiant Biosciences is a research-based global pharmaceutical company which develops, registers and commercializes novel and effective therapies addressing patient needs and…” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 24 | 8 contacts → | ||||
Indirect evidence “Albert Labs (CSE: ABRT) is a bio-pharmaceutical company pursuing licensing approval for active compounds from natural sources; providing access to effective prescription medicines…” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
| 25 | 8 contacts → | ||||
Indirect evidence “MGC Pharmaceuticals Limited ("MGC")(MXC: LSE, ASX) is a next-generation Pharma licensed company at the forefront of the emerging global plant-inspired pharmaceutical market.” Source: RevenueBase Database · checked Sep 20, 2026Thanks. The Data Team will review it. | |||||
RevenueBase Smart Search
RevenueBase Smart Search assesses information from a company’s LinkedIn profile, information supplied directly by the company, its website, and other publicly available sources. It uses that information to rate how closely the company relates to this list’s category: neuroscience drug developers. Every row carries its rating and the description the rating was read from, so each one can be checked rather than taken on trust.
- Strong evidence
- The company's own public description of its business names neuroscience drug developers.
- Partial evidence
- Its own public description names part of neuroscience drug developers, so it works in or next to the category without describing itself that way.
- Indirect evidence
- The description shown does not name neuroscience drug developers. The match rests on the rest of the company's public profile rather than the one sentence quoted here, so this is the rating to check first.
RevenueBase Smart Search is how these lists are built: RevenueBase's data engine and AI assemble the companies that match a category defined in a user's own words, so a list can be about what companies actually do rather than about whichever industry code they were filed under.
Showing 25 of 79 neuroscience drug developers based in the United Kingdom
See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 1,240 reachable decision-makers.
Free signup · no credit card
Neuroscience drug developers based in the United Kingdom at a glance
As of Sep 20, 2026Companies by employee count
Email recency for this list is measured worldwide rather than for United Kingdom, so it is reported there. Company counts and contact totals on this page are exact for United Kingdom, over 79 companies.
How this list was built
Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among neuroscience drug developers, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.
- Source
- The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
- What qualifies
- Companies headquartered in the United Kingdom whose own description of what they do matches “neuroscience drug developers”. Matching reads each company's description, not its industry code or its name.
- RevenueBase Smart Search
- RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names neuroscience drug developers), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
- What we exclude
- Companies whose own description does not clearly place them among neuroscience drug developers, and records with no verified work email. Companies headquartered outside United Kingdom are excluded even when they keep an office there.
- Match quality
- In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
- Ranking
- Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
- Verification
- Every listed company carries at least one verified work email, 1,240 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
- Refresh
- This page's figures were pulled from the company graph on September 20, 2026. Lists refresh periodically as the graph is re-checked.
- Corrections
- Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.
Neuroscience drug developers by metro
- Neuroscience drug developers in London30
Frequently asked
What is RevenueBase Smart Search?
RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names neuroscience drug developers, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.
How many neuroscience drug developers are there based in the United Kingdom?
RevenueBase identified 79 neuroscience drug developers headquartered in the United Kingdom as of September 2026, matched on each company's own description of what it does rather than its industry code.
What is the largest company on this list?
Sygnature Discovery, headquartered in Nottingham, tops this list with the largest team on record.
Which city has the most neuroscience drug developers?
London leads with 30 headquartered companies, followed by Cambridge (6) and Oxford (6).
How do I get contact information for these companies?
A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 1,240 verified decision-maker contacts tracked across these 79 companies.
How current is this list?
The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 20, 2026.
Ready to reach these companies? Verified emails and direct dials for all 79 neuroscience drug developers based in the United Kingdom. Start with a free account, no credit card.
Download this list →Related lists
Neuroscience drug developers by geography
- Neuroscience drug developers based in Boston, United States
- Neuroscience drug developers based in New York, United States
- Neuroscience drug developers based in San Diego, United States
- Neuroscience drug developers based in Australia
- Neuroscience drug developers based in Canada
- Neuroscience drug developers based in France
- Neuroscience drug developers based in Germany
- Neuroscience drug developers based in India
- Neuroscience drug developers based in Spain
- Neuroscience drug developers based in Switzerland
- Neuroscience drug developers based in the United States
About this data
RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.
More company lists
- All company lists
- Lists by location
- Lists A-Z
- New lists
- Neuroscience drug developers based in Boston, United States
- Neuroscience drug developers based in New York, United States
- Neuroscience drug developers based in San Diego, United States
- Neuroscience drug developers based in Australia
- Neuroscience drug developers based in Canada
- Neuroscience drug developers based in France